ISTA PHARMACEUTICALS INC
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY11 | FY10 | FY09 | |
|---|---|---|---|
| Revenue | $160.3M | $156.5M | $110.6M |
| Operating income | $19,000 | $10.4M | $2.1M |
| Net income | −$56.6M | −$5.3M | −$57.8M |
| Total assets | $153.1M | $134.2M | — |
| Total liabilities | $202.2M | $213.3M | — |
| Equity | −$49.1M | −$79.1M | −$78.0M |
| EPS (diluted) | — | — | — |
| Shares out. | 41.6M | 33.6M | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2011- Operating margin
- 0.0%
- Net margin
- −35.3%
- Return on equity
- 115.4%
- Return on assets
- −37.0%
- Return on capital (ROCE)
- 0.1%
- Liabilities / assets
- 132.1%
- Debt / equity
- —
- Book value / share
- $-1.18
- Revenue growth (YoY)
- 2.4%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2011- Altman Z″ (distress)
- -9.93distress
- Accruals / assets
- −34.7%clean
- Beneish M-Score
- -3.39normal
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 3 warning● 4 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 12, 2009
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsJun 6, 2012
- Shareholder vote · Other material eventJun 5, 2012
- Entered a material agreement · Other material eventMay 24, 2012
- Results of operationsMay 4, 2012
- Other material eventApr 24, 2012
- Other material eventApr 17, 2012
- Entered a material agreement · New financial obligationApr 3, 2012
- Other material eventApr 2, 2012
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.